Sight Sciences Cash on Hand 2021-2024 | SGHT
Sight Sciences cash on hand from 2021 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Sight Sciences Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $120 |
| 2023 | $138 |
| 2022 | $185 |
| 2021 | $261 |
| 2020 | $62 |
| Sight Sciences Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-12-31 | $120 |
| 2024-09-30 | $119 |
| 2024-06-30 | $118 |
| 2024-03-31 | $127 |
| 2023-12-31 | $138 |
| 2023-09-30 | $145 |
| 2023-06-30 | $155 |
| 2023-03-31 | $167 |
| 2022-12-31 | $185 |
| 2022-09-30 | $200 |
| 2022-06-30 | $220 |
| 2022-03-31 | $239 |
| 2021-12-31 | $261 |
| 2021-09-30 | $271 |
| 2021-06-30 | $36 |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.158B | $0.080B |
| Sight Sciences Inc. is a medical device company. It focused on the development and commercialization of proprietary devises which target the underlying causes of prevalent eye diseases. Sight Sciences Inc. is based in MENLO PARK, Calif. | |||